Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 04/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Bausch Health Ireland Limited
*MAILING ADDRESS
3013 Citywest Business Campus
*CITY
Dublin
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Ireland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
24
PHONE
585-338-8049
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
private company limited by shares (prc)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
003
*IDENTIFICATION
Non-medicated dermatologic substances and preparations, namely, moisturizers, creams, powders, gels, solutions, shampoos, sprays, swabs,
washes, ointments, and topical antibiotics to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses;
Non-medicated oral health substances preparations in the form of powders, creams, rinses for the treatment of periodontitis, mouth dryness, cold sores, mouth ulcers.
At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis
for registration, but is only asserting a valid claim of priority. The application should not be suspended to await the submission of the foreign registration.
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucousitis and bone and
soft tissue regeneration; dental rinse for oral health; Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans
including constipation, hepatic encephalopathy, irritable bowel syndrome, opioid-induced constipation and ulcerative colitis; Medicated beverages, powders, and gels for colonoscopies and endoscopic
procedures; Pharmaceutical preparations and substances to prevent and treat diabetes mellitus, epilepsy, migraines, anxiety and depression, chronic pain, headaches, psychiatric disorders, and rare
diseases such as Wilson and Huntington's disease, diabetes mellitus, cardiovascular/angina, hyperammonaemia, hormone deficiencies (endocrinology), cancer, otolaryngology, and urinary tract , lungs,
heart infections and diseases, central nervous system disorders, neuromuscular conditions, vaginal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical
preparations and substances for the treatment of skin and nail conditions, namely, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections;
Vitamins and mineral supplements.
At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis
for registration, but is only asserting a valid claim of priority. The application should not be suspended to await the submission of the foreign registration.
INTERNATIONAL CLASS
010
*IDENTIFICATION
Radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; Medical devices
for aesthetic and therapeutic applications for the skin and its subcutaneous structures, namely, a device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency
devices for medical and aesthetic treatment; Medical devices, namely medical instruments designed for the non-invasive removal of human body fat using an external energy source.
At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis
for registration, but is only asserting a valid claim of priority. The application should not be suspended to await the submission of the foreign registration.
ATTORNEY INFORMATION
NAME
John F. Ward
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Bausch Health
INTERNAL ADDRESS
Law Department
STREET
1400 N. Goodman Street
CITY
Rochester
STATE
New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
14609
PHONE
585-338-8049
EMAIL ADDRESS
trademarks@bausch.com
CORRESPONDENCE INFORMATION
NAME
John F. Ward
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
trademarks@bausch.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
holly.smith@bausch.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1050
*TOTAL FEES PAID
1050
SIGNATURE INFORMATION
SIGNATURE
/Holly M. Smith/
SIGNATORY'S NAME
Holly M. Smith
SIGNATORY'S POSITION
Legal Operations Manager - Trademarks
SIGNATORY'S PHONE NUMBER
585-338-8049
DATE SIGNED
04/25/2021
SIGNATURE METHOD
Signed directly within the form
PTO- 1478
Approved for use through 04/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90669899
Filing Date:04/25/2021
To the Commissioner for Trademarks:
MARK: LUMAN (Standard Characters, see mark)
The literal element of the mark consists of LUMAN. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Bausch Health Ireland Limited, a private company limited by shares (prc) legally organized under the laws of Ireland, having an address of
3013 Citywest Business Campus
Dublin 24
Ireland
585-338-8049(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 003: Non-medicated dermatologic substances and preparations, namely, moisturizers, creams, powders, gels, solutions, shampoos, sprays, swabs, washes, ointments, and topical
antibiotics to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses; Non-medicated oral health
substances preparations in the form of powders, creams, rinses for the treatment of periodontitis, mouth dryness, cold sores, mouth ulcers.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Ireland application number 2021/00670, filed 03/26/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis for registration, but
is only asserting a valid claim of priority. The application should not be suspended to await the submission of the foreign registration.
International Class 005: Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucousitis and bone and soft tissue regeneration;
dental rinse for oral health; Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation,
hepatic encephalopathy, irritable bowel syndrome, opioid-induced constipation and ulcerative colitis; Medicated beverages, powders, and gels for colonoscopies and endoscopic procedures;
Pharmaceutical preparations and substances to prevent and treat diabetes mellitus, epilepsy, migraines, anxiety and depression, chronic pain, headaches, psychiatric disorders, and rare diseases such
as Wilson and Huntington's disease, diabetes mellitus, cardiovascular/angina, hyperammonaemia, hormone deficiencies (endocrinology), cancer, otolaryngology, and urinary tract , lungs, heart
infections and diseases, central nervous system disorders, neuromuscular conditions, vaginal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical
preparations and substances for the treatment of skin and nail conditions, namely, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections;
Vitamins and mineral supplements.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Ireland application number 2021/00670, filed 03/26/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis for registration, but
is only asserting a valid claim of priority. The application should not be suspended to await the submission of the foreign registration.
International Class 010: Radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and
therapeutic applications for the skin and its subcutaneous structures, namely, a device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical
and aesthetic treatment; Medical devices, namely medical instruments designed for the non-invasive removal of human body fat using an external energy source.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Ireland application number 2021/00670, filed 03/26/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis for registration, but
is only asserting a valid claim of priority. The application should not be suspended to await the submission of the foreign registration.
The owner's/holder's proposed attorney information: John F. Ward. John F. Ward of Bausch Health, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
Law Department
1400 N. Goodman Street
Rochester, New York 14609
United States
585-338-8049(phone)
trademarks@bausch.com
John F. Ward submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Holly M. Smith/ Date: 04/25/2021
Signatory's Name: Holly M. Smith
Signatory's Position: Legal Operations Manager - Trademarks
Signatory's Phone Number: 585-338-8049
Signature method: Signed directly within the form
Payment Sale Number: 90669899
Payment Accounting Date: 04/26/2021
Serial Number: 90669899
Internet Transmission Date: Sun Apr 25 16:12:25 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2021042516122556
9651-90669899-780326d75ff97b28e1746fa01f
8088f3915fcaae4341fafb0704dab8731b27df-D
A-12252711-20210425160938315779